文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

感染相关住院后老年人抗精神病药物的停用情况

Antipsychotic Medication Use Among Older Adults Following Infection-Related Hospitalization.
PubMed 文献 · JAMA Netw Open · 2023-02-01
一句话结论感染相关住院后新启动的抗精神病药物中,30天内停用率氟哌啶醇为52.1%,非典型抗精神病药仅11.4%(P<.001),且氟哌啶醇停用率逐年上升。

这项回顾性队列研究使用2004年1月1日至2022年5月31日美国理赔数据,纳入5835例65岁及以上、无既往精神疾病、在感染相关住院30天内新启动抗精神病药物处方的患者,比较口服氟哌啶醇(790例)与非典型抗精神病药物(5045例)的停用率。主要终点停用定义为配药结束后超过15天的间隙。结果显示,启动后30天累积停用率非典型抗精神病药物为11.4%(95%CI 10.4%-12.3%),氟哌啶醇为52.1%(95%CI 48.2%-55.7%),差异P<.001;2004至2022年氟哌啶醇停用率每年增加5%(95%CI 3%-7%,校正HR 1.05 [1.03-1.07],P<.001),非典型抗精神病药物无此趋势(HR 1.00 [0.99-1.01],P=.67)。住院时间延长和痴呆与两类药物停用均呈负相关。

要点

  • 感染相关住院后新启动的抗精神病药物30天累积停用率:氟哌啶醇52.1%(95%CI 48.2%-55.7%)vs 非典型抗精神病药物11.4%(95%CI 10.4%-12.3%),P<.001。
  • 停用定义为配药结束后超过15天的间隙;氟哌啶醇组790例(13.5%),非典型抗精神病药物组5045例(86.5%)。
  • 2004至2022年氟哌啶醇停用率每年增加5%(95%CI 3%-7%),校正HR 1.05(1.03-1.07),P<.001;非典型抗精神病药物无此趋势(HR 1.00 [0.99-1.01],P=.67)。
  • 住院时间延长和痴呆与氟哌啶醇及非典型抗精神病药物的停用均呈负相关。
  • 研究提示,感染相关住院后新启动用于谵妄的抗精神病药物中,非典型抗精神病药物使用者停用率低于氟哌啶醇使用者,住院时间延长和痴呆是主要相关变量。

适用人群与场景

  • 美国65岁及以上老年人,无既往精神疾病,在感染相关住院30天内新启动抗精神病药物处方(口服氟哌啶醇或非典型抗精神病药物)。
  • 数据来源为Optum去标识化Clinformatics Data Mart数据库,覆盖2004年1月1日至2022年5月31日。

诊断标准与关键阈值

  • 新用药定义:队列入组前任何时间均未使用过该药。
  • 停用定义:抗精神病药物配药结束后超过15天的间隙。

研究设计与关键结果

  • 研究类型:回顾性队列研究;样本量5835例;人群为美国65岁及以上、无既往精神疾病、感染相关住院后30天内新启动抗精神病药物者。
  • 氟哌啶醇组790例(13.5%),平均(SD)年龄81.5(6.7)岁,女性422例(53.4%);非典型抗精神病药物组5045例(86.5%),平均(SD)年龄79.8(7.0)岁,女性2636例(52.2%)。
  • 启动后30天累积停用率:非典型抗精神病药物11.4%(95%CI 10.4%-12.3%)vs 氟哌啶醇52.1%(95%CI 48.2%-55.7%),P<.001。
  • 2004至2022年停用率趋势:氟哌啶醇每年增加5%(95%CI 3%-7%),校正HR 1.05(1.03-1.07),P<.001;非典型抗精神病药物HR 1.00(0.99-1.01),P=.67。
  • 住院时间延长和痴呆与氟哌啶醇及非典型抗精神病药物的停用均呈负相关。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,感染相关住院后新启动用于谵妄的抗精神病药物中,非典型抗精神病药物使用者的停用率低于氟哌啶醇使用者,住院时间延长和痴呆是主要相关变量。
  • 作者认为,近年来氟哌啶醇停用率显著升高,而非典型抗精神病药物无此趋势。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: There are limited data on discontinuation rates of antipsychotic medications (APMs) used to treat delirium due to acute hospitalization in the routine care of older adults.

OBJECTIVE: To investigate discontinuation rates and patient characteristics of APMs used to treat delirium following infection-related hospitalization among older US adults.

DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study was conducted using US claims data (Optum's deidentified Clinformatics Data Mart database) for January 1, 2004, to May 31, 2022. Patients were aged 65 years or older without prior psychiatric disorders and had newly initiated an APM prescription within 30 days of an infection-related hospitalization. Statistical analysis was performed on December 15, 2022.

EXPOSURES: New use (no prior use any time before cohort entry) of oral haloperidol and atypical APMs (aripiprazole, olanzapine, quetiapine, risperidone, etc).

MAIN OUTCOMES AND MEASURES: The primary outcome was APM discontinuation, defined as a gap of more than 15 days following the end of an APM dispensing. Survival analyses and Kaplan-Meier analyses were used.

RESULTS: Our study population included 5835 patients. Of these individuals, 790 (13.5%) were new haloperidol users (mean [SD] age, 81.5 [6.7] years; 422 women [53.4%]) and 5045 (86.5%) were new atypical APM users (mean [SD] age, 79.8 [7.0] years; 2636 women [52.2%]). The cumulative incidence of discontinuation by 30 days after initiation was 11.4% (95% CI, 10.4%-12.3%) among atypical APM users and 52.1% (95% CI, 48.2%-55.7%) among haloperidol users (P < .001 for difference between haloperidol vs atypical APMs). We observed an increasing trend in discontinuation rates from 2004 to 2022 (5% increase [95% CI, 3%-7%] per year) for haloperidol users (adjusted hazard ratio, 1.05 [1.03-1.07]; P < .001) but not for atypical APM users (1.00 [0.99-1.01]; P = .67). Prolonged hospitalization and dementia were inversely associated with the discontinuation of haloperidol and atypical APMs.

CONCLUSIONS AND RELEVANCE: The findings of this cohort study suggest that the discontinuation rate of newly initiated APMs for delirium following infection-related hospitalization was lower in atypical APM users than in haloperidol users, with prolonged hospitalization and dementia as major associated variables. The discontinuation rate was substantially higher in recent years for haloperidol but not for atypical APMs.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Zhang Y, Wilkins JM, Bessette LG, et al. Antipsychotic Medication Use Among Older Adults Following Infection-Related Hospitalization. JAMA Netw Open. 2023. PMID: 36800180. doi:10.1001/jamanetworkopen.2023.0063

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。